Bitome
Ginkgo Bioworks is a leading horizontal platform for cell programming that provides flexible, end-to-end synthetic biology services across diverse markets including food, agriculture, pharmaceuticals, industrial, and specialty chemicals. The company leverages a $1 billion R&D platform combining highly automated labs, AI tools, and deep scientific expertise to accelerate research and development projects. Ginkgo offers custom R&D solutions, packaged services, and low-cost R&D tools to solve complex biological challenges, enabling partners to program cells like computers using DNA code. Their platform supports industries such as agriculture, biopharma, biosecurity, government, and industrial biotechnology, positioning Ginkgo as a key innovation partner in synthetic biology with broad market reach and advanced technological capabilities.
Bitome
Ginkgo Bioworks is a leading horizontal platform for cell programming that provides flexible, end-to-end synthetic biology services across diverse markets including food, agriculture, pharmaceuticals, industrial, and specialty chemicals. The company leverages a $1 billion R&D platform combining highly automated labs, AI tools, and deep scientific expertise to accelerate research and development projects. Ginkgo offers custom R&D solutions, packaged services, and low-cost R&D tools to solve complex biological challenges, enabling partners to program cells like computers using DNA code. Their platform supports industries such as agriculture, biopharma, biosecurity, government, and industrial biotechnology, positioning Ginkgo as a key innovation partner in synthetic biology with broad market reach and advanced technological capabilities.